TREM2 and amyloidosis: Genetic variants of genes such as CD33 and TREM2 have been shown to alter (increase or decrease) the phagocytic functions of microglia and thus may directly (or indirectly) contribute to tau pathology, independent of their potential effects on amyloid pathology.